Find Federal Grants
Centers for Disease Control - NCCDPHP · CDC-RFA-DP19-1907
American Indians into Nursing
Indian Health Service · HHS-2019-IHS-NU-0001
American Indians into Psychology
Indian Health Service · HHS-2019-IHS-INPSY-0001
American Indians into Medicine
Indian Health Service · HHS-2019-IHS-INMED-0001
Service Area Competition
Health Resources and Services Administration · HRSA-20-015
Rapid Response to Ebola Viral Disease in West Africa through Strengthening of Surveillance Systems and Disruption of Chain of Transmission Interventions
Centers for Disease Control - CGH · CDC-RFA-GH15-16290401SUPP19
Rapid Assessment of Drug Abuse: Smart City Tools (R43/R44 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-021
Rapid Assessment of Drug Abuse: Smart City Tools (R41/R42 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-020
National Institutes of Health · PAR-19-281
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-19-282
Private Sector Partnership Addressing Emerging Zoonoses and Antimicrobial Resistance
Agency for International Development · GH-BAA-2018-ADDENDUM02
Centers for Disease Control - NCHHSTP · CDC-RFA-PS20-2002
Health Resources and Services Administration · HRSA-19-109
Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-284
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
National Institutes of Health · PAR-19-283
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
National Institutes of Health · PAR-19-285
Technical Assistance for Response to Public Health or Healthcare Crises: OPIOID SUPPLEMENTAL
Centers for Disease Control - OSTLTS · CDC-RFA-OT18-18040101SUPP19
Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-018
Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-017
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)
National Institutes of Health · PAR-19-280